Key Takeaways:
UnitedHealth Group (NYSE: UNH) posted first-quarter earnings that surpassed Wall Street estimates, sending its shares up more than 7 percent as an improvement in medical costs signaled a potential turnaround.
"The results validate our strategy," CEO Stephen Hemsley said in a statement. "We are seeing the benefits of our disciplined execution and strategic repositioning."
The healthcare giant reported adjusted earnings of $7.23 per share on revenue of $111.7 billion. Analysts had projected $6.58 in earnings per share and $109.4 billion in revenue. The company’s medical care ratio, a measure of premiums paid out for medical care, fell to 83.9 percent from 91.5 percent in the fourth quarter of 2025.
Shares surged in response to the news, building on recent momentum after a favorable Medicare rate announcement. The company raised its full-year adjusted EPS forecast to over $18.25 and authorized a $2 billion stock buyback, providing a further boost to investor confidence.
The improved medical cost trend comes after a difficult period for the insurer, which faced rising patient care costs and reduced government reimbursement rates in 2025. In response, UnitedHealth has been exiting less profitable individual ACA marketplace plans and certain Medicare Advantage regions. This led to a membership decline to 49.1 million in the first quarter from 49.8 million at the end of 2025.
The company's Optum Health division also showed signs of recovery, with adjusted operating earnings of $1.3 billion. UnitedHealth is investing at least $1.5 billion in artificial intelligence this year to help manage costs and offset a $6 billion headwind from Medicare reimbursement changes.
The strong quarter and positive guidance suggest UnitedHealth's cost-control measures are taking hold. Investors will be watching the second-quarter results to see if the improvement in the medical care ratio is sustainable.
This article is for informational purposes only and does not constitute investment advice.
